These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1825247)

  • 1. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1991 Feb; 51(2):486-90. PubMed ID: 1825247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity of intracellular signals responsible for cell cycle progression to cyclosporine.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1990 Jan; 49(1):186-91. PubMed ID: 1689083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of prolyl-peptidyl isomerase to mediate cyclosporine suppression of intracellular activation signal generation.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1991 Feb; 51(2):509-13. PubMed ID: 1994547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
    Combates NJ; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication.
    Kimball PM; Kerman RK; Van Buren CT; Lewis RM; Katz S; Kahan BD
    Transplantation; 1993 May; 55(5):1128-32. PubMed ID: 8497893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
    Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H
    Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
    Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
    Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
    Citterio F; Kahan BD
    Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A directly inhibits human B-cell proliferation by more than a single mechanism.
    Hannam-Harris AC; Taylor DS; Nowell PC
    J Leukoc Biol; 1985 Aug; 38(2):231-9. PubMed ID: 3875675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
    Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
    Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
    Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
    Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.